Web Search Site Search
HCV Patient Assistance Programs (click here for details)
Merck Zepatier Patient Assistance Program (click here for details)
Abbvie G/P, Mavyret Patient Support (click here for details)
Gilead Hepatitis C Patient Assistance Program - Epclusa, Vosevi, Harvoni, Sovaldi (sofosbuvir) (click here for details)
Ryan White Care Act Hepatitis C & B Language (click here for details)
HCV Copayment Assistance - HealthWell Foundation (click here for details)
icon star paper Current HIV Articles and News Updates
  News Updates  
icon paper stack Current Hepatitis C and B Articles
  Hepatitis C  
  Hepatitis B  
icon_eye_hilite.gif Check Out Our Special NATAP Features
  1. Coming of AGE. A guide to ageing well with HIV - 06/15/11

  2. La informacion Que Necesitas Sobre el VIH - 06/15/10

  3. New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07

  4. Do you have HIV/HCV Coinfection? - 11/28/06

  5. HIV 101 : The Basics - 11/28/06

  6. VIH 101 : Lo Basico - in Spanish - 11/28/06

  7. HIV 102 : Care and Treatment of HIV - 11/28/06

  8. VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06

  9. Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V

  10. Download More NATAP Publications...

Support provided by: Support Provided by: Abbvie, Genentech, Gilead, Janssen Therapeutics, Merck, Roche, & ViiV
icon_person.gif Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin
If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.
Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157.
Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.
New Pegasys Patient Assistance Program
has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.
866 422-2377